Ribomic Inc. (4591.T)
JPY 88.0
(-1.12%)
JPY 88.0
(-1.12%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -10.5 Million JPY | -115.92% |
| 2022 | 65.96 Million JPY | -18.47% |
| 2021 | 80.9 Million JPY | -12.02% |
| 2020 | 91.96 Million JPY | -24.0% |
| 2019 | 121 Million JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 1 Million JPY | 126.03% |
| 2023 Q1 | -1.62 Million JPY | -102.59% |
| 2023 Q2 | -2.45 Million JPY | -50.83% |
| 2023 Q4 | -3.84 Million JPY | -48.59% |
| 2023 Q3 | -2.58 Million JPY | -5.47% |
| 2023 FY | -10.5 Million JPY | -115.92% |
| 2022 Q3 | -80 Thousand JPY | -108.0% |
| 2022 FY | 65.96 Million JPY | -18.47% |
| 2022 Q4 | 62.63 Million JPY | 78395.0% |
| 2022 Q2 | 1 Million JPY | 0.0% |
| 2021 FY | 80.9 Million JPY | -12.02% |
| 2020 FY | 91.96 Million JPY | -24.0% |
| 2019 FY | 121 Million JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 1.88 Billion JPY | 100.558% |
| PRISM BioLab Co.,LTD | 80.3 Million JPY | 113.077% |
| GNI Group Ltd. | 22.43 Billion JPY | 100.047% |
| Linical Co., Ltd. | 3.77 Billion JPY | 100.278% |
| Trans Genic Inc. | 2.24 Billion JPY | 100.467% |
| MEDINET Co., Ltd. | 98.25 Million JPY | 110.689% |
| Soiken Holdings Inc. | 2.48 Billion JPY | 100.423% |
| Cytori Cell Research Institute, Inc. | 1.29 Billion JPY | 100.812% |
| AnGes, Inc. | -3.06 Billion JPY | 99.657% |
| OncoTherapy Science, Inc. | -177.71 Million JPY | 94.091% |
| Nxera Pharma Co., Ltd. | 9.66 Billion JPY | 100.109% |
| Immuno-Biological Laboratories Co., Ltd. | 517.29 Million JPY | 102.03% |
| NanoCarrier Co., Ltd. | 110.95 Million JPY | 109.465% |
| Carna Biosciences, Inc. | 1.45 Billion JPY | 100.724% |
| CanBas Co., Ltd. | -984 Million JPY | 98.933% |
| D. Western Therapeutics Institute, Inc. | 391.69 Million JPY | 102.681% |
| RaQualia Pharma Inc. | 1.65 Billion JPY | 100.634% |
| Chiome Bioscience Inc. | 398.59 Million JPY | 102.635% |
| Kidswell Bio Corporation | 1.03 Billion JPY | 101.01% |
| PeptiDream Inc. | 17.21 Billion JPY | 100.061% |
| Oncolys BioPharma Inc. | 30.6 Million JPY | 134.315% |
| SanBio Company Limited | -14.5 Million JPY | 27.592% |
| Healios K.K. | 108 Million JPY | 109.724% |
| BrightPath Biotherapeutics Co., Ltd. | -341 Thousand JPY | -2979.765% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -59.04 Million JPY | 82.214% |
| Delta-Fly Pharma, Inc. | -1.51 Million JPY | -594.577% |
| StemRIM | -44.34 Million JPY | 76.32% |
| CellSource Co., Ltd. | 3.18 Billion JPY | 100.33% |
| FunPep Company Limited | -680.28 Million JPY | 98.456% |
| Kringle Pharma, Inc. | 69.25 Million JPY | 115.165% |
| Stella Pharma Corporation | 217.29 Million JPY | 104.833% |
| TMS Co., Ltd. | -6.95 Million JPY | -51.108% |
| Noile-Immune Biotech Inc. | 314.56 Million JPY | 103.339% |
| Cuorips Inc. | 9.63 Million JPY | 209.044% |
| K Pharma,Inc. | 910 Million JPY | 101.154% |
| Takara Bio Inc. | 25.45 Billion JPY | 100.041% |
| ReproCELL Incorporated | 1.1 Billion JPY | 100.951% |
| PhoenixBio Co., Ltd. | 1.19 Billion JPY | 100.879% |
| StemCell Institute Inc. | 1.57 Billion JPY | 100.666% |
| Japan Tissue Engineering Co., Ltd. | 1.66 Billion JPY | 100.63% |
| CellSeed Inc. | 107.15 Million JPY | 109.801% |